EICHOR
● Active Not Recruiting
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Condition: Metastatic Castration-resistant Prostate Cancer · Sponsor: Fusion Pharmaceuticals Inc.
About this study
This is an open-label, randomized, multicenter study of FPI-2265 (225Ac-PSMA-I\&T). Patient population is adult participants with PSMA positive mCRPC who have had previous treatment with with 177Lu-PSMA-617 or another 177Lu-PSMA radioconjugate (RC). The purpose of the study is to determine the safety and tolerability, and recommended dose and regiment of FPI-2265.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (18)
| City of Hope Comprehensive Cancer Center | Duarte, California, United States | — |
| Hoag Health Center Irvine | Irvine, California, United States | — |
| VA Greater Los Angeles Healthcare System | Los Angeles, California, United States | — |
| University of California Los Angeles | Los Angeles, California, United States | — |
| UCSF School of Medicine | San Francisco, California, United States | — |
| Biogenix Molecular, LLC | Miami, Florida, United States | — |
| University of Iowa Hospitals and Clinics | Iowa City, Iowa, United States | — |
| United Theranostics | Glen Burnie, Maryland, United States | — |
| BAMF Health | Grand Rapids, Michigan, United States | — |
| SSM Health Saint Louis University Hospital | St Louis, Missouri, United States | — |
| XCancer | Omaha, Nebraska, United States | — |
| New Mexico Oncology Hematology Consultants Ltd. | Albuquerque, New Mexico, United States | — |
+ 6 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.